Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes

The

is reporting that Amgen

is close to a deal to acquire Onyx Pharmaceuticals

for $125 per share. The deal could be announced on Monday, according to sources. Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals closed Friday at $116.96.